Your browser doesn't support javascript.
loading
Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity.
Cui, Lu; Chen, Shih-Yu; Lerbs, Tristan; Lee, Jin-Wook; Domizi, Pablo; Gordon, Sydney; Kim, Yong-Hun; Nolan, Garry; Betancur, Paola; Wernig, Gerlinde.
Afiliação
  • Cui L; Department of Pathology, Institute of Stem Cell Biology and Regenerative Medicine (ISCBRM), Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Chen SY; Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.
  • Lerbs T; Department of Pathology, Institute of Stem Cell Biology and Regenerative Medicine (ISCBRM), Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Lee JW; Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Domizi P; Department of Pathology, Institute of Stem Cell Biology and Regenerative Medicine (ISCBRM), Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Gordon S; Orca Biosystems, 3475 Edison Way, Suite B, Menlo Park, 94025, CA, USA.
  • Kim YH; Department of Pathology, Institute of Stem Cell Biology and Regenerative Medicine (ISCBRM), Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Nolan G; Baxter Laboratories Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Betancur P; Department of Radiation Oncology, University of California, San Francisco, 94143, CA, USA.
  • Wernig G; Department of Pathology, Institute of Stem Cell Biology and Regenerative Medicine (ISCBRM), Stanford University School of Medicine, Stanford, 94305, CA, USA. gwernig@stanford.edu.
Nat Commun ; 11(1): 2795, 2020 06 03.
Article em En | MEDLINE | ID: mdl-32493933
ABSTRACT
The transcription factor JUN is highly expressed in pulmonary fibrosis. Its induction in mice drives lung fibrosis, which is abrogated by administration of anti-CD47. Here, we use high-dimensional mass cytometry to profile protein expression and secretome of cells from patients with pulmonary fibrosis. We show that JUN is activated in fibrotic fibroblasts that expressed increased CD47 and PD-L1. Using ATAC-seq and ChIP-seq, we found that activation of JUN rendered promoters and enhancers of CD47 and PD-L1 accessible. We further detect increased IL-6 that amplified JUN-mediated CD47 enhancer activity and protein expression. Using an in vivo mouse model of fibrosis, we found two distinct mechanisms by which blocking IL-6, CD47 and PD-L1 reversed fibrosis, by increasing phagocytosis of profibrotic fibroblasts and by eliminating suppressive effects on adaptive immunity. Our results identify specific immune mechanisms that promote fibrosis and suggest a therapeutic approach that could be used alongside conventional anti-fibrotics for pulmonary fibrosis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Proteínas Proto-Oncogênicas c-jun / Fibroblastos / Imunidade Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Proteínas Proto-Oncogênicas c-jun / Fibroblastos / Imunidade Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos